David E. Lazar - Net Worth and Insider Trading

David E. Lazar Net Worth

The estimated net worth of David E. Lazar is at least $0 dollars as of 2024-06-12. David E. Lazar is the CEO, 10% Owner of Titan Pharmaceuticals Inc and owns about 0 shares of Titan Pharmaceuticals Inc (TTNP) stock worth over $0. Details can be seen in David E. Lazar's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David E. Lazar has not made any transactions after 2023-06-21 and currently still holds the listed stock(s).

Transaction Summary of David E. Lazar

To

David E. Lazar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David E. Lazar owns 1 companies in total, including Titan Pharmaceuticals Inc (TTNP) .

Click here to see the complete history of David E. Lazar’s form 4 insider trades.

Insider Ownership Summary of David E. Lazar

Ticker Comapny Transaction Date Type of Owner
TTNP Titan Pharmaceuticals Inc 2023-06-21 director & 10 percent owner & Chief Executive Officer

David E. Lazar Latest Holdings Summary

David E. Lazar currently owns a total of 1 stock. David E. Lazar owns 0 shares of Titan Pharmaceuticals Inc (TTNP) as of June 21, 2023, with a value of $0.

Latest Holdings of David E. Lazar

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TTNP Titan Pharmaceuticals Inc 2023-06-21 0 6.94 0

Holding Weightings of David E. Lazar


David E. Lazar Form 4 Trading Tracker

According to the SEC Form 4 filings, David E. Lazar has made a total of 4 transactions in Titan Pharmaceuticals Inc (TTNP) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Titan Pharmaceuticals Inc is the sale of 187,398 shares on June 21, 2023, which brought David E. Lazar around $5 Million.

Insider Trading History of David E. Lazar

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David E. Lazar Trading Performance

GuruFocus tracks the stock performance after each of David E. Lazar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David E. Lazar is 2.34%. GuruFocus also compares David E. Lazar's trading performance to market benchmark return within the same time period. The performance of stocks bought by David E. Lazar within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David E. Lazar's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David E. Lazar

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 26.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 23.34 LIMIT LIMIT LIMIT LIMIT LIMIT

David E. Lazar Ownership Network

Ownership Network List of David E. Lazar

No Data

Ownership Network Relation of David E. Lazar

Insider Network Chart

David E. Lazar Owned Company Details

What does Titan Pharmaceuticals Inc do?

Who are the key executives at Titan Pharmaceuticals Inc?

David E. Lazar is the director & 10 percent owner & Chief Executive Officer of Titan Pharmaceuticals Inc. Other key executives at Titan Pharmaceuticals Inc include 10 percent owner Seow Gim Shen , 10 percent owner Sire Group Ltd. , and director & President and COO Katherine Beebe .

Titan Pharmaceuticals Inc (TTNP) Insider Trades Summary

Over the past 18 months, David E. Lazar made 3 insider transaction in Titan Pharmaceuticals Inc (TTNP) with a net sale of 7,438,436.

In summary, during the past 3 months, insiders sold 0 shares of Titan Pharmaceuticals Inc (TTNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 374,797 shares of Titan Pharmaceuticals Inc (TTNP) were sold and 2,875 shares were bought by its insiders, resulting in a net sale of 371,922 shares.

Titan Pharmaceuticals Inc (TTNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Titan Pharmaceuticals Inc Insider Transactions

No Available Data

David E. Lazar Mailing Address

Above is the net worth, insider trading, and ownership report for David E. Lazar. You might contact David E. Lazar via mailing address: Villa 1, 14-43rd Street, Jumeirah 2, Dubai C0 00000.

Discussions on David E. Lazar

No discussions yet.